196 related articles for article (PubMed ID: 32892693)
1. Lighting up the fire in cold tumors to improve cancer immunotherapy by blocking the activity of the autophagy-related protein PIK3C3/VPS34.
Janji B; Hasmim M; Parpal S; De Milito A; Berchem G; Noman MZ
Autophagy; 2020 Nov; 16(11):2110-2111. PubMed ID: 32892693
[TBL] [Abstract][Full Text] [Related]
2. Firing up the cold tumors by targeting Vps34.
Janji B; Hasmim M; Parpal S; Berchem G; Noman MZ
Oncoimmunology; 2020 Aug; 9(1):1809936. PubMed ID: 32939326
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1/PD-L1 immunotherapy.
Noman MZ; Parpal S; Van Moer K; Xiao M; Yu Y; Viklund J; De Milito A; Hasmim M; Andersson M; Amaravadi RK; Martinsson J; Berchem G; Janji B
Sci Adv; 2020 May; 6(18):eaax7881. PubMed ID: 32494661
[TBL] [Abstract][Full Text] [Related]
4. Improving STING agonist-based cancer therapy by inhibiting the autophagy-related protein VPS34.
Bartolini E; Van Moer K; Janji B
Oncoimmunology; 2024; 13(1):2364958. PubMed ID: 38872753
[TBL] [Abstract][Full Text] [Related]
5. Autophagy-related protein PIK3C3/VPS34 controls T cell metabolism and function.
Yang G; Song W; Postoak JL; Chen J; Martinez J; Zhang J; Wu L; Van Kaer L
Autophagy; 2021 May; 17(5):1193-1204. PubMed ID: 32268825
[TBL] [Abstract][Full Text] [Related]
6. A Novel Tri-Functional Liposome Re-Educates "Cold Tumor" and Abrogates Tumor Growth by Synergizing Autophagy Inhibition and PD-L1 Blockade.
Zhou F; Li X; Xue X; Li S; Fan G; Cai Y; Chang Z; Qu J; Liu R
Adv Healthc Mater; 2023 Apr; 12(11):e2202757. PubMed ID: 36652763
[TBL] [Abstract][Full Text] [Related]
7. PIK3C3/VPS34 control by acetylation.
Su H; Liu W
Autophagy; 2018; 14(6):1086-1087. PubMed ID: 28980854
[TBL] [Abstract][Full Text] [Related]
8. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
9. An alcoholic extract of Thuja orientalis L. leaves inhibits autophagy by specifically targeting pro-autophagy PIK3C3/VPS34 complex.
Jung J; Chun Y; Jang YP; Oh MS; Kim JH; Kim J
Sci Rep; 2021 Sep; 11(1):17712. PubMed ID: 34489486
[TBL] [Abstract][Full Text] [Related]
10. Development of in vitro PIK3C3/VPS34 complex protein assay for autophagy-specific inhibitor screening.
Kim TM; Baek JH; Kim JH; Oh MS; Kim J
Anal Biochem; 2015 Jul; 480():21-7. PubMed ID: 25862085
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of anti-PD-1/PD-L1 immunotherapy for osteosarcoma using an intelligent autophagy-controlling metal organic framework.
Ge YX; Zhang TW; Zhou L; Ding W; Liang HF; Hu ZC; Chen Q; Dong J; Xue FF; Yin XF; Jiang LB
Biomaterials; 2022 Mar; 282():121407. PubMed ID: 35217343
[TBL] [Abstract][Full Text] [Related]
12. Recent advances of vacuolar protein-sorting 34 inhibitors targeting autophagy.
Chen L; Gao T; Zhou P; Xia W; Yao H; Xu S; Xu J
Bioorg Chem; 2024 Feb; 143():107039. PubMed ID: 38134519
[TBL] [Abstract][Full Text] [Related]
13. 4-1BB Agonism Combined With PD-L1 Blockade Increases the Number of Tissue-Resident CD8+ T Cells and Facilitates Tumor Abrogation.
Qu QX; Zhu XY; Du WW; Wang HB; Shen Y; Zhu YB; Chen C
Front Immunol; 2020; 11():577. PubMed ID: 32391001
[TBL] [Abstract][Full Text] [Related]
14. Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy.
Benoit A; Vogin G; Duhem C; Berchem G; Janji B
Cells; 2023 Jul; 12(13):. PubMed ID: 37443821
[TBL] [Abstract][Full Text] [Related]
15. Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy.
McAuliffe J; Chan HF; Noblecourt L; Ramirez-Valdez RA; Pereira-Almeida V; Zhou Y; Pollock E; Cappuccini F; Redchenko I; Hill AV; Leung CSK; Van den Eynde BJ
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34479921
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell-intrinsic CD274/PD-L1: A novel metabolic balancing act with clinical potential.
Clark CA; Gupta HB; Curiel TJ
Autophagy; 2017 May; 13(5):987-988. PubMed ID: 28368722
[TBL] [Abstract][Full Text] [Related]
17. Autophagy-related protein Vps34 controls the homeostasis and function of antigen cross-presenting CD8α
Parekh VV; Pabbisetty SK; Wu L; Sebzda E; Martinez J; Zhang J; Van Kaer L
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):E6371-E6380. PubMed ID: 28716903
[TBL] [Abstract][Full Text] [Related]
18. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
Han X; Li H; Zhou D; Chen Z; Gu Z
Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988
[TBL] [Abstract][Full Text] [Related]
19. The Role of Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 in the Pathogenesis of Human Cancer.
Chu CA; Wang YW; Chen YL; Chen HW; Chuang JJ; Chang HY; Ho CL; Chang C; Chow NH; Lee CT
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681622
[TBL] [Abstract][Full Text] [Related]
20. A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy.
Takeda Y; Kataoka K; Yamagishi J; Ogawa S; Seya T; Matsumoto M
Cell Rep; 2017 May; 19(9):1874-1887. PubMed ID: 28564605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
